Identity and percentage holding of significant shareholders
| Shares held | % | |
|---|---|---|
| Substantial holdings | ||
| Calculus Capital | 3,327,163 | 17.80% |
| Odey Asset Management | 1,998,254 | 10.69% |
| Hargreave Hale | 1,608,038 | 8.60% |
| M&G Investments Mgt | 1,248,490 | 6.68% |
| River & Mercantile Asset Mgt | 1,055,000 | 5.64% |
| Directors and related shareholders | ||
| Catherine Booth | 980,000 | 5.24% |
| Allan Brown | 51,999 | 0.28% |
| Ian Gilham | 114,250 | 0.61% |
| David Budd | 31,250 | 0.17% |
| Roger Lloyd | 12,500 | 0.07% |
| Robert Nolan | 5,065 | 0.03% |
| Total Directors' holdings | 1,195,064 | 6.39% |
| Dr B Cobb | 491,228 | 2.63% |
| Remaining shares in public hands | 17,003,154 | 89.21% |
| Total shares in issue | 18,689,446 | 100.00% |
Details of other current and future exchanges on which securities are traded
London AIM market - Listed 4 April 2007
The number of securities in issue
18,689,446 AIM securities in issue
The percentage of securities not in public hands
Detailed below
Country of incorporation
United Kingdom
Main region of operation
United Kingdom
Details of any restrictions on the transfer of AIM securities
No restrictions on transfer
Latest reports
29 March 2018
21 March 2018 Capital Networks - Note on Genedrive's Interim Results
Investor News
Tuesday April 10, 2018
Genedrive has Hepatitis C test performance data published in leading medical journal
Tuesday April 03, 2018
Genedrive to premiere Hepatitis C test at Asia-Pacific medical exhibition
Tuesday March 27, 2018
Genedrive extends global coverage with new distribution agreement in India
© 2017-18 genedrive plc
This site uses cookies for tracking and statistical purposes. Please read our 